2015
DOI: 10.1016/j.exger.2014.11.014
|View full text |Cite
|
Sign up to set email alerts
|

Estimation of sarcopenia prevalence using various assessment tools

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
82
2
3

Year Published

2015
2015
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 116 publications
(88 citation statements)
references
References 23 publications
1
82
2
3
Order By: Relevance
“…The EWGSOP selected BIA as it is the most valid, reliable and feasible method of measuring muscle mass within field settings [29]. However, compared to dual-energy X-ray absorptiometry, BIA may overestimate muscle mass, leading to an underestimation of the prevalence of sarcopenia [29,30]. Due to the extent of missing data on disease status and medications during data collection, this data was considered unreliable and not included in the logistic regression analyses.…”
Section: Discussionmentioning
confidence: 99%
“…The EWGSOP selected BIA as it is the most valid, reliable and feasible method of measuring muscle mass within field settings [29]. However, compared to dual-energy X-ray absorptiometry, BIA may overestimate muscle mass, leading to an underestimation of the prevalence of sarcopenia [29,30]. Due to the extent of missing data on disease status and medications during data collection, this data was considered unreliable and not included in the logistic regression analyses.…”
Section: Discussionmentioning
confidence: 99%
“…Despite the original, strict definition of sarcopenia, more recent classifications have incorporated various indices of muscle performance (e.g., strength) or mobility function (e.g., gait speed), apparently in an effort to build clinical relevance and diagnostic criteria. However, the introduction of functional correlates has only confused the diagnosis (Beaudart et al, 2015; Beaudart et al, 2014a); thus we have elected to describe the phenomenon as simply ‘aging muscle atrophy’.…”
Section: Fighting Metabolic Disease and Muscle Atrophy: Warding Off Smentioning
confidence: 99%
“…[3]) reported a systematic overestimation of muscle mass when compared with DXA. However, others and we [37][38][39] do not share this position.…”
Section: Limitationsmentioning
confidence: 99%
“…Thus, the progressively increasing cohort of older people with SO are at particular risk of negative health impact such as loss of independence, disability and increased morbidity and mortality [2]. Although the relevance of this Bgeriatric syndrome^is considered to be high, its prevalence in older persons living in the community is unclear and may depend on different Sarcopenia and Sarcopenic Obesity definitions and approaches [1,3].…”
Section: Introductionmentioning
confidence: 99%